PubRank
Search
About
Nicole M Scharenborg
Author PubWeight™ 15.01
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.
Cancer Res
2003
2.32
2
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.
Clin Cancer Res
2003
1.57
3
Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome.
J Clin Oncol
2005
1.48
4
Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.
Clin Cancer Res
2010
1.45
5
Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines.
Int J Cancer
2007
1.42
6
Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.
Clin Cancer Res
2011
1.29
7
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.
Cancer Immunol Immunother
2008
1.15
8
Phenotypical and functional characterization of clinical grade dendritic cells.
J Immunother
2002
1.12
9
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used.
Cancer Immunol Immunother
2010
1.04
10
Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients.
Anticancer Res
2010
0.96
11
Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination.
Nucl Med Biol
2006
0.77
12
Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4(+) T lymphocytes.
Int J Cancer
2002
0.76